Following its release, GLP-1(736) is quickly degraded by dipeptidyl peptidase 4 (DPP-4) to form the metabolite GLP-1(936), which lacks insulin-releasing capacity [7], and only 1015% of the GLP-1 released in the gut reaches the pancreatic islets [5]
It does not create a branded finished drug, it does not trigger insurance coverage, and it does not retroactively validate marketing claims made about the compound
(2020) Effects of kefir or milk supplementation on zonulin in overweight subjects
Resources: Zhao, X., Zhang, X., & Liu, D
If you are in Marietta and looking for a weight loss supplement, Lipotropic Injection is what you need